Related Experiment Video
Updated: Aug 15, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Overview of bronchiolitis
May S Chehab1, Hend A Bafagih, Maha M Al-Dabbagh
1Department of Pediatrics, Armed Forces Hospital, PO Box 7897, Riyadh 1159, Kingdom of Saudi Arabia. maychehab@hotmail.com
Insights
Respiratory syncytial virus (RSV) causes significant infant infections, influenced by viral and host factors. Supportive care is primary, but early adjunctive therapies may aid airway obstruction in severe cases.
Area of Science:
- Virology
- Pediatrics
- Immunology
Background:
- Respiratory syncytial virus (RSV) is a common cause of infant respiratory infections.
- RSV pathogenesis involves viral factors (e.g., strain virulence) and host factors (e.g., asthma history, immune status).
- Epithelial cell responses, including cytokine and chemokine release, drive inflammation during RSV infection.
Purpose of the Study:
- To review the complex factors influencing RSV infection and its treatment in infants.
- To discuss current and emerging therapeutic strategies for RSV bronchiolitis.
Main Methods:
- Literature review of RSV pathogenesis and treatment modalities.
- Analysis of viral and host interactions in RSV disease.
- Evaluation of supportive care and adjunctive therapies for RSV bronchiolitis.
Main Results:
- RSV infection is multifactorial, involving viral virulence, inoculum size, and host susceptibility.
- Inflammatory responses initiated by epithelial cells are central to RSV-induced airway disease.
- Supportive care (oxygen, fluids) remains the cornerstone of RSV bronchiolitis management.
- Emerging evidence suggests early adjunctive therapies can benefit infants with airway obstruction, particularly in severe cases.
Conclusions:
- RSV bronchiolitis treatment is challenging due to its complex etiology.
- While supportive care is essential, early and judicious use of adjunctive therapies may improve outcomes for specific patient groups.
- Further research into targeted therapies for RSV is warranted.
Abstract:
Respiratory syncytial virus RSV, a nonsegmented, single stranded ribonucleic acid virus, infects one-half of all infants within the first year of life. Respiratory syncytial virus possesses pathogenetic qualities that may be attributed to the interplay of viral and host-specific factors including virus strains of different virulence, size of the inoculum, family history of asthma or airway hyper-reactivity and immunologic anomalies of the host. Inflammatory cell recruitment and activation occur in response to RSV infection of epithelial cells. Epithelial cells initiate the inflammatory response to RSV by elaborating a wide variety of cytokines and chemokines that trigger further inflammatory responses. Treatment of RSV in infants with bronchiolitis is complicated due to the multifactorial nature of this infection. Treatment of RSV bronchiolitis rests primarily on supportive care with oxygen and fluid management. Other therapies commonly used include bronchodilators, corticosteroids and ribavirin, where considered appropriate. Although oxygen administration and judicious fluid replacement are the only interventions proved to be of reliable benefit to infants with bronchiolitis, newer studies support a role for adjunctive therapies aimed at relieving airway obstruction, especially when administered very early in the course of the illness or given to infants with more severe disease.
More Related Videos
Related Concept Videos
The Bronchial Tree
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
Pulmonary Cycle: Exhalation
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Respiratory Syncytial Virus Disease
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Pneumonia I: Introduction

